Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Add shares to your
quickpicks to
display them here!

Arix Bioscience (ARIX)

Price 114.50p on 22-09-2023 at 16:30:02
Change 0.50p 0.44%
Buy 116.00p
Sell 113.00p
Buy / Sell ARIX Shares
Last Trade: Unknown 30.00 at 114.50p
Day's Volume: 7,988
Last Close: 114.50p
Open: 114.50p
ISIN: GB00BD045071
Day's Range 114.50p - 116.00p
52wk Range: 97.00p - 124.00p
Market Capitalisation: £148m
VWAP: 114.13084p
Shares in Issue: 129m

Recent Trades History Arix Bioscience (ARIX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 30 114.50p Negotiated Trade
15:36:53 - 22-Sep-23
Sell* 1,000 113.67p Ordinary
12:02:13 - 22-Sep-23
Buy* 1,001 114.89p Ordinary
10:22:25 - 22-Sep-23
Sell* 1,021 113.63p Ordinary
10:22:25 - 22-Sep-23
Buy* 68 116.00p Suspected BUY Trade
10:00:21 - 22-Sep-23
Buy* 2,175 114.89p Ordinary
07:54:40 - 22-Sep-23
Sell* 2,407 113.61p Ordinary
07:29:11 - 22-Sep-23
Sell* 286 113.00p Ordinary
07:02:53 - 22-Sep-23

Share Price History for Arix Bioscience

Time period:
Date Open High Low Close Volume

Share News for Arix Bioscience

UK earnings, trading statements calendar - next 7 days

20th Sep 2023 15:50

Read More

IN BRIEF: Arix Bioscience reports dip in portfolio value in July

7th Aug 2023 10:38

Arix Bioscience PLC - venture capital company focused on investing in breakthrough biotechnology companies - Reports a net asset value per share of GBP1.84 as at July 31, down from GBP1.86 as at June 30. Listed portfolio value falls to GBP69 million as at July 31 from GBP71.2 million as at June 30. Read More

UK earnings, trading statements calendar - next 7 days

2nd Aug 2023 15:46

Read More

Arix Bioscience launches strategic review despite value increase

13th Jul 2023 16:55

(Alliance News) - Arix Bioscience PLC on Thursday announced its net asset value had increased, but that it plans to launch a strategic review concerning issues like its discounted share price. Read More

IN BRIEF: Arix Bio portfolio company Disc raises USD157.8 million

23rd Jun 2023 14:28

Arix Bioscience PLC - London-headquartered venture capital company focused on biotechnology companies - Says its portfolio company Disc Medicine has raised USD157.8 million via a placing of 3.0 million new shares and pre-funded warrants to purchase 204,081 shares. Says the shares were sold at USD49.00 per share. Says Disc will use the funds for the research and clinical development of its current or additional product candidates, as well as for working capital. Notes that Arix's holding in Disc has reduced from 3.1% to 2.7% following the placing. Read More

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered